Company profile
VIA Pharmaceuticals, Inc.
OTC: VIAP · Healthcare · Medical - Pharmaceuticals
PublicHQ San Francisco, Reports USD
#1161 of 1,417 Healthcare companies by revenue
EA Score
——FH —DQ —GM —SS 36
v0.1 · 5/100 weight · pillars only
↑ listing tenure, disclosure history · ↓ Piotroski F, return on assets
Methodology →Revenue TTM
$0
Rev growth YoY (TTM)
needs 8 qtrs
Net income (FY)
-$9.6M
Employees
6
as of 2026-08-29
Market cap
$10.3k
as of 2026-08-29
Financials — latest annual
SEC EDGAR · USD-normalizedConceptUSDNativeFY
Revenue$0$02010
Net income-$9.6M-$9.6M2010
Operating income-$6.0M-$6.0M2010
Total assets$500.0k$500.0k2010
Liabilities$19.0M$19.0M2010
Equity-$18.5M-$18.5M2010
Revenue trend
FY2003 – FY2010 · USD
FY03
FY04
FY05
FY06
FY07
FY08
FY09
FY10
Revenue by segment
No segmentation disclosed for this filer. n/a
The read
What is VIA Pharmaceuticals, Inc.’s revenue?
VIA Pharmaceuticals, Inc. booked $0 in FY2010 revenue — among the slowest-growing Healthcare companies we track, at a -Infinity% net margin.
Peers · Healthcare
Eco Science Solutions, Inc.33DCardioGenics Holdings Inc——Manhattan Scientifics, Inc.——OneLife Technologies Corp.——Capital Group Holdings, Inc.——RenovaCare, Inc.——Key facts
CEOThomas Quertermous
SectorHealthcare
IndustryMedical - Pharmaceuticals
HeadquartersSan Francisco, null
ExchangeOTC: VIAP
Employees6
IPO date2007-06-06
Latest filings
No filings loaded — no CIK (non-SEC filer).
Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.